Navigation Links
QLT acquires leading edge ocular drug delivery system from ForSight Labs
Date:10/8/2007

uarters by obtaining a mortgage or other financial structures.

"We are very excited to work with the experienced drug and device development teams at QLT to advance this technology," said Eugene de Juan Jr., M.D., Founder and Vice-Chairman of ForSight Labs. "We think this is a very significant technology that could ultimately lead to a sea of change in the way medications are delivered to the eye."

ForSight Newco II's proprietary punctal plugs are a non-invasive drug delivery system capable of delivering a variety of drugs to the eye over time through controlled release to the tear film. Sustained release punctal plugs could potentially replace eye drops for glaucoma, dry eye, allergies and postoperative care, which represent a $6 billion market. In addition, plugs may provide a more effective, convenient and reliable treatment alternative that could ultimately improve patient compliance with their medication and outcomes for their disease.

Through this acquisition, QLT, through its wholly-owned subsidiary, will obtain worldwide rights to commercialize ForSight Newco II's proprietary punctal plug technology combined with any active pharmaceutical ingredient, and will lead and fund future development efforts in this program. QLT plans to initiate a Phase I/II clinical trial with the first product using ForSight Newco II's proprietary technology for the treatment of glaucoma in the first half of 2008. Glaucoma affects approximately 65 million people worldwide and is the second leading cause of blindness. Approximately 99% of glaucoma patients are treated with topical medications, 4-6% receive surgery and on average each diagnosed patient has multiple visits to ophthalmologist per year. Compliance with topical eye drop medications in glaucoma patients is poor, with approximately half of treated patients not refilling their prescription after the first six months of therapy. In spite of this, the glaucoma market continues to grow and in the U.S. repres
'/>"/>

SOURCE QLT Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ossur Acquires the U.S. Orthopaedics Company
2. Stem of Hope: Stem Cell Research Acquires a Brittle Star As A model
3. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
4. Premier Army Hospital Acquires PET-CT Scanner
5. Wockhardt acquires Protinex, Farex brands from Netherland Co
6. Indoco Remedies Acquires La Nova Chem
7. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
8. AIIMS Acquires Four-Armed Robot to Assist in Surgeries
9. Apollos Global Arm Acquires US-based Firm
10. ‘Obesity’ Acquires Permanent Resident Status in the US
11. Indias Wockhardt Acquires Irish Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Atlantic Information Services, Inc. (AIS) is ... of Health Plans: 2015 , the all-new 12th edition ... health plan market, with enrollment data and contact information ... , Available as a printed book containing the full ... quick-view tables and charts, as well as an electronic ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 What are ... should physicians request references? When are interviews scheduled, how ... employment opportunities?, Both training and practicing physicians who are ... these questions and more at the PracticeLink Physician Career ... The drop-in Job Fair is from 5:30 to 8:30 ...
(Date:3/2/2015)... Viejo, California (PRWEB) March 02, 2015 ... release of the TranStatic Volume 2 from Pixel Film Studios. ... transitions made exclusively for FCPX,” said Christina Austin, CEO of ... to have in any Final Cut Pro X editors toolbox.” ... scene to the next with media altering static scrambling effects ...
(Date:3/1/2015)... is pleased to announce the addition of a digital library ... over 75 terms and phrases available for viewing, with more being ... a better understanding of what our Providers are talking about when ... this resource, our patients are able to go back to the ... they may not remember or comprehend at the time of their ...
(Date:3/1/2015)... New York (PRWEB) March 01, 2015 ... hip lawsuit (( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go ... defense must prepare a witness to provide testimony ... in the development of the Profemur device, Bernstein ... in U.S. District Court, Northern District of Iowa ...
Breaking Medicine News(10 mins):Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3
... ... Valuable Incentives Are Still Available , ... (Vocus) April 20, 2010 -- Toll Brothers, the nation,s leading builder of luxury ... 24 until May 2. With the slight rise in interest rates recently, and conventional wisdom ...
... ... nutritional products and services exclusive to health care professionals, announced today the nationwide launch ... ... Inc. , a leading national provider of nutritional products and services exclusive to health ...
... next decade to protect public health , TUESDAY, April 20 ... take steps to lower the amount of salt in the ... Tuesday. , In a report from the Institute of Medicine, ... the federal government on public health issues, the panel recommended ...
... ... designed to help the immune system; to return the gut back to health after antibiotics, ... the company that brought Waterfall D-Mannose to the world. , ... (PRWeb UK) April 19, 2010 -- The natural health products ...
... 2010 Elsevier, the world-leading publisher of scientific, technical ... the Faculty of Travel Medicine of the Royal College ... Travel Medicine and Infectious Disease has been ... of Travel Medicine. RCPSG,s Faculty of Travel ...
... multi-center study led by a researcher at Rhode Island ... hemodialysis patients are at increased risk of carrying methicillin-resistant ... study also found that patients have vastly different quantities ... their risk of developing an infection after surgery. The ...
Cached Medicine News:Health News:Spring Into A New Toll Brothers Dream Home During the National Spring Sales Event April 24 - May 2 2Health News:Spring Into A New Toll Brothers Dream Home During the National Spring Sales Event April 24 - May 2 3Health News:Spring Into A New Toll Brothers Dream Home During the National Spring Sales Event April 24 - May 2 4Health News:New Designs for Health Probiotic Toothpaste -- A Breakthrough in Oral Health 2Health News:New Designs for Health Probiotic Toothpaste -- A Breakthrough in Oral Health 3Health News:New Designs for Health Probiotic Toothpaste -- A Breakthrough in Oral Health 4Health News:New Designs for Health Probiotic Toothpaste -- A Breakthrough in Oral Health 5Health News:Experts Urge FDA to Lower Salt in American Diet 2Health News:Experts Urge FDA to Lower Salt in American Diet 3Health News:Experts Urge FDA to Lower Salt in American Diet 4Health News:Anna & John's Special Probiotic Blend™ Just Released by Sweet Cures™, the Innovative Natural Health Products Company based in York, UK 2Health News:Who is at risk for MRSA? 2
(Date:3/2/2015)... LEBANON, N.J. and BETHESDA, Md. ... clinical development-stage immunotherapy company focused on treating and preventing ... Phase 2-stage, anti-IL-15 monoclonal antibody (AMG 714) from Amgen ... this exclusive license agreement, Celimmune has the rights to ... basis excluding Japan . Concurrently, Amgen ...
(Date:3/2/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it ... 2014 on March 9, 2015. The Company also plans to hold ... 2015, at 5:00 pm ET. The call will be hosted by ... , , , LIVE CALL:  , , , (877) ... , , , , , , ...
(Date:3/1/2015)... , March 1, 2015  Patients suffering from ... against this debilitating foot ailment, according to research ... ,s Annual Scientific Meeting . Researchers utilized ... emulsify and remove diseased fasciitis tissue. Permanently removing ... to regrow in its place, restoring normal function. ...
Breaking Medicine Technology:Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 2Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 3ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3
... Neuradiab(TM) compares favorably to data from other, ... 17 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc.,(TSX: BMR), a ... cancer therapies, today released progression free,survival (PFS) data ... in glioblastoma multiforme (GBM) patients. As an exploratory,endpoint ...
... Conn., July 16 Biodel Inc. (Nasdaq:,BIOD) today announced ... now complete, with the last study patient visit on ... released either at Biodel,s poster,presentation at the European Association ... 2008, or at a later appropriate scientific forum., ...
Cached Medicine Technology:Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 3Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 4Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 5Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 2Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 3Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 4Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 5
... has been a key participant in the ... than a decade. Previous Medtronic autotransfusion systems ... platelets, as well as to determine requirements ... platelet-rich plasma (PRP) for a small amount ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
... System combines low-profile, high radial force, and excellent ... compatible stent system provides 6F sheath / 8F ... 10.0 mm). Now, with longer stents available, the ... lengths (28, 38, 56, 80 and 100 mm) ...
... Supreme and Response catheters comprise the ... available for electrophysiology procedures. Their advanced ... for superior torque response with a ... curves and French sizes, Supreme and ...
Medicine Products: